Concepedia

Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators

Laura Gonzalez‐Fajardo, Olga Lucía Fernández, Diane McMahon‐Pratt, Nancy Gore Saravia

PLoS neglected tropical diseases · 2015 · 24 citations · 58 references

DOIFull text

Open access

Abstract

Human PBMCs allow integrated ex vivo assessment of antileishmanial treatments, providing information on host and parasite determinants of therapeutic response that may be used to tailor therapeutic strategies to optimize clinical resolution.

References

58

Isolation of Lymphocytes, Granulocytes and Macrophages

Arne Bøyum · Scandinavian Journal of Immunology · 1976 · 1.6K citations

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Jeong Han, Patricia A. Thompson, Bruce Beutler · The Journal of Experimental Medicine · 1990 · 506 citations · Full text

, , +15

A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection

Koert Ritmeijer, Abren Dejenie, Yibeltal Assefa et al. · Clinical Infectious Diseases · 2006 · 217 citations · Full text

Resistance to Antimony and Treatment Failure in Human <i>Leishmania (Viannia)</i> Infection

Ricardo Rojas, Liliana Valderrama, Mabel Valderrama et al. · The Journal of Infectious Diseases · 2006 · 183 citations

Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in<i>Leishmania donovani</i>-Infected Macrophages

Jayati Basu, Ananda Mookerjee, Prosenjit Sen et al. · Antimicrobial Agents and Chemotherapy · 2006 · 175 citations · Full text

, , +23